BioVersys AG | Finanzwire

Basculer en Français

9971	Companies
201993	Keywords
132602	Articles
107253	Press releases

Home
Companies
BioVersys AG

BRIEF

published on 03/04/2026 at 07:05, 3 hours 33 minutes ago

BioVersys Publishes BV100 Phase 1 Clinical Data

Clinical Trial BV100 BioVersys Pharmacokinetics Acinetobacter Baumannii
PRESS RELEASE

published on 03/04/2026 at 07:00, 3 hours 38 minutes ago

BioVersys Announces Publication of BV100 Phase 1 Clinical Data in Journal of Antimicrobial Agents and Chemotherapy
BioVersys announces publication of BV100 Phase 1 clinical data in Journal of Antimicrobial Agents and Chemotherapy

Clinical Data Phase 1 BV100 BioVersys Antibacterial
BRIEF

published on 02/19/2026 at 07:22, 13 days 3 hours ago

BioVersys Achieves Breakthrough in Tuberculosis Treatment

Phase 2A Trial Drug Resistance Tuberculosis Alpibectir Collaborative Research
PRESS RELEASE

published on 02/19/2026 at 07:17, 13 days 3 hours ago

BioVersys and partners’ phase 2a tuberculosis trial results published in New England Journal of Medicine
BioVersys and partners demonstrate promising results with AlpE in Phase 2a tuberculosis trial, published in New England Journal of Medicine. AlpE shows potential in treating drug-resistant tuberculosis

Clinical Trial Drug Resistance BioVersys Tuberculosis AlpE
BRIEF

published on 12/11/2025 at 07:05, 2 months 24 days ago

BioVersys Initiates Phase 3 Trial for BV100 and Updates Business Progress

IPO Drug Resistance BioVersys BV100 Phase 3 Antibacterial Research
PRESS RELEASE

published on 12/11/2025 at 07:00, 2 months 24 days ago

BioVersys Announces BV100 Phase 3 Initiation and Provides a Business Update
BioVersys AG initiates BV100 Phase 3 study for ventilator-associated bacterial pneumonia, achieving significant milestones in 2025 and upcoming key events in 2026

Clinical Trials Biopharmaceutical BioVersys AG BV100 Phase 3 Ventilator Associated Bacterial Pneumonia
BRIEF

published on 11/10/2025 at 07:05, 3 months 24 days ago

BioVersys' BV100 Phase 2B Study Set for Asia

Phase 2B Trial Drug Resistance BioVersys BV100 Wellcome Funding ADVANCE-ID Network
PRESS RELEASE

published on 11/10/2025 at 07:00, 3 months 24 days ago

BioVersys BV100 Phase 2B to be conducted via Wellcome Funded Trial Network
BioVersys BV100 Phase 2B to be conducted via Wellcome Funded Trial Network. BioVersys AG leads Phase 2 trial for innovative antibacterial product BV100

Phase 2b Clinical Trial BV100 BioVersys Wellcome Funded Trial Network
BRIEF

published on 11/06/2025 at 07:05, 3 months 28 days ago

BioVersys Advances BV100 Clinical Trials in China

Clinical Trials BV100 BioVersys MDR Bacteria Acinetobacter
PRESS RELEASE

published on 11/06/2025 at 07:00, 3 months 28 days ago

Bioversys ANNOUNCES FIRST SUBJECTS DOSED IN PHASE 1 CLINICAL TRIAL OF BV100 in CHInA
BioVersys announces the dosing of the first subject in a Phase 1 clinical trial with BV100 in China. BV100 targets MDR hospital infections caused by Acinetobacter baumannii

Phase 1 Clinical Trial BV100 BioVersys MDR Bacteria Acinetobacter Baumannii

1 2 ... 5

Accesswire

Published on 03/04/2026 at 08:07, 2 hours 31 minutes ago

Mako Mining Shareholders Overwhelmingly Approve the Mt. Hamilton Acquisition
Published on 03/03/2026 at 22:30, 12 hours 8 minutes ago

Sparta Capital Ltd Releases Q1 Financial Results
Published on 03/03/2026 at 19:40, 14 hours 58 minutes ago

NRCan Awards Nano One $3M To Support LFP Cathode Material Supply Chain Initiative
Published on 03/03/2026 at 17:00, 17 hours 38 minutes ago

MWC 2026: Vodafone Germany Multi-Year Transformation Reaches Commercial Launch with Amdocs
Published on 03/03/2026 at 15:00, 19 hours 38 minutes ago

Star Copper Announces Upsize To Flow Through Financing

View all ACCESSWIRE

EQS Group

Published on 03/04/2026 at 10:27, 11 minutes ago

Original-Research: Schaeffler AG (von Quirin Privatbank Kapitalmarktgeschäft): BUY
Published on 03/04/2026 at 10:05, 33 minutes ago

Rockwell Automation Announces Ronal Group Will Modernize Remote Access With New, Centralized System
Published on 03/04/2026 at 10:00, 38 minutes ago

Shanghai Electric Provides Core Equipment for World's Largest Compressed Air Energy Storage Station Now Fully Operational in Jiangsu, China
Published on 03/04/2026 at 10:00, 38 minutes ago

HomeToGo to list its high-quality vacation rental inventory on KAYAK
Published on 03/04/2026 at 09:38, 59 minutes ago

Hager Group accelerates B2B commerce transformation with Intershop

Les Echos

Published on 03/04/2026 at 07:02, 3 hours 36 minutes ago

TERACT - Availibility of the Half-year Financial Report As of 31 December 2025
Published on 03/04/2026 at 07:02, 3 hours 36 minutes ago

TERACT - H1 2025-2026 results
Published on 03/03/2026 at 18:09, 16 hours 29 minutes ago

TF1 - Monthly disclosure of the total number of shares and voting rights - February 2026
Published on 03/03/2026 at 18:00, 16 hours 38 minutes ago

Covivio - Information on total number of voting rights and share capital
Published on 03/03/2026 at 17:43, 16 hours 55 minutes ago

Aéroports de Paris SA - Shares and voting rights as of 28 February 2026

View all LES ECHOS COMFI WIRE